Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02266784 · ClinicalTrials.gov registry record · Phase 1
Contingency Management, Quitting Smoking, and ADHD
A Phase 1 study of Smoking Cessation and Cigarette Smoking, sponsored by Duke University.
- Completed
- Registry status
- Phase 1
- Development phase
- 33
- Enrollment target
- 1
- Study location
NCT02266784 is a Phase 1 study of Smoking Cessation and Cigarette Smoking that has completed, run by Duke University. The registered enrollment target is 33 participants, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02266784, a Phase 1 study of Smoking Cessation and Cigarette Smoking, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of the study is to evaluate how motivation and readiness for change are influenced in the context of a smoking cessation attempt. A total of 60 adult (i.e. age 18-55) smokers (N=40 with ADHD; N=20 without ADHD) who are interested in quitting will be enrolled into a 3-arm trial allocated as follows. Twenty of the ADHD smokers and the 20 non-ADHD smokers will be assigned to a traditional 8-week contingency management intervention in which monetary payments will be made contingent upon biologically verified evidence of smoking abstinence. The 20 additional ADHD smokers will be assigned to a treatment-as-usual condition (nicotine replacement; supportive counseling). During the treatment phase, subjects will be required to answer questions 4x/week in their daily lives via an EMA (Ecological Momentary Assessment). Specific Aim 1: To assess motivation to quit smoking and readiness for change prior to a quit attempt in treatment seeking ADHD and non-ADHD smokers. Hypothesis 1a: The investigators hypothesize that prior to a quit attempt, smokers with ADHD will exhibit significantly lower levels of intrinsic motivation to quit, and equal or higher levels of extrinsic motivation to quit compared to smokers without ADHD. Hypothesis 1b: The investigators hypothesize that smokers with ADHD will exhibit relatively less readiness for change than smokers without ADHD. Specific Aim 2: To assess how baseline levels of motivation to quit and readiness for change are influenced during a quit attempt as a function of both ADHD status and treatment modality. Hypothesis 2a. The investigators hypothesize that the CM intervention will result in relatively greater change in extrinsic motivation to quit versus intrinsic motivation to quit, and that this effect will be more pronounced among ADHD smokers. Hypothesis 2b: The investigators hypothesize that overall motivation to quit (intrinsic and extrinsic) and readiness for change will be significantly influenced by the CM int
Conditions Studied
Interventions
- BEHAVIORAL Contingency Management (CM)
- DRUG Transdermal nicotine skin patches (i.e. Habitrol)
- OTHER Supportive Counseling
Study Locations (1)
North Carolina
- Duke Child and Family Study Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2014-10 |
| Est. Completion | 2017-12-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02266784
The ClinicalTrials.gov registry entry for NCT02266784 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (93% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 3 interventions - of which Contingency Management (CM) is the first listed.
NCT02266784 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT02266784 about?
NCT02266784 is a clinical study titled "Contingency Management, Quitting Smoking, and ADHD". The overall goal of the study is to evaluate how motivation and readiness for change are influenced in the context of a smoking cessation attempt. A total of 60 adult (i.e. age 18-55) smokers (N=40 with ADHD; N=20 without ADHD) who are interested in quitting will be enrolled into a 3-arm trial alloc...
What is the current status of trial NCT02266784?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 33 participants. The study started on 2014-10. Estimated completion is 2017-12-08.
What conditions does trial NCT02266784 study?
This clinical trial studies the following conditions: Smoking Cessation, Cigarette Smoking.
What interventions are being tested in trial NCT02266784?
The interventions under investigation include: Contingency Management (CM) (BEHAVIORAL), Transdermal nicotine skin patches (i.e. Habitrol) (DRUG), Supportive Counseling (OTHER).
Who is sponsoring clinical trial NCT02266784?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02266784 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Overcoming Nicotine Dependence to Enable Quitting
RECRUITING · Phase 1
-
Concurrent vs. Sequential Cessation of Dual Cigarette and E-cigarette Use
RECRUITING · Phase 1
-
Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients
RECRUITING · Phase 1
-
Harnessing the Power of Technology: MOMBA for Postpartum Smoking
COMPLETED · Phase 1
-
A Phase I Study to Evaluate the Pharmacokinetics of Multiple Doses of Varenicline in Healthy Adolescent Smokers
COMPLETED · Phase 1
-
Intervention for Support Persons to Help Smokers Quit
COMPLETED · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.